Company News

bioMérieux takes a proactive, partnership-driven approach to combating AMR with diagnostic and data-driven solutions to improve stewardship efforts. To further this goal, bioMérieux created the AMS Centers of Excellence (CoE) designation awarded to hospitals around the world as a sign of a joint commitment to best AMS practices.

bioMérieux and NecstGen, collaborate to accelerate the development of Cell and Gene Therapies (CGT) through the provision of ‘state of the art’ and rapid quality and safety testing technologies that will allow safe and effective advanced therapeutics production.

For 20 years, bioMérieux and the Hospices Civils de Lyon (HCL) have been collaborating in an innovative public/private research partnership. Joined in 2016 by Claude Bernard Lyon 1 University, the three institutions are working to figure out the mechanisms of immunity in order to develop diagnostic tests.

bioMérieux, a world leader in in vitro diagnostics for more than 55 years, and Jackson Family Wines, the global, family-owned wine company based in Sonoma County, California, are pleased to announce the worldwide availability of BOTTLESAFE™.

bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the incorporation of the company’s innovative GENE-UP^® QUANT Salmonella assay into the methodology used by the USDA Food Safety Inspection Service regional laboratories.